Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.34 |
| ▸ | MAPT | P10636 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 4/20 | 0.34 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21667125 | 0.97 | MAPT (0.36) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL23026224 | 0.95 | MEN1 (0.33) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL21666763 | 0.95 | MEN1 (0.33) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL21667131 | 0.95 | MEN1 (0.33) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL21671123 | 0.95 | MAPT (0.36) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL26416520 | 0.93 | MEN1 (0.32) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL23026325 | 0.93 | CYP1A1 (0.34) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL21666764 | 0.92 | MAPT (0.35) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL26416818 | 0.91 | MAPT (0.32) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL21671431 | 0.91 | PTGER4 (0.33) | MAPTALDH1A1HPGDKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11527723-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2022-12-13 | — | — | US | disclosed |
| EP-3604296-B1 | ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT | LT MATERIALS CO LTD (KR) | 2021-07-28 | — | — | EP | disclosed |
| US-20210057651-A1 | ORGANIC LIGHT EMITTING DEVICE, METHOD FOR MANUFACTURING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| US-20200123133-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | HEESUNG MATERIAL LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
| EP-3604298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | Heesung Material Ltd. (KR) | 2020-02-05 | — | — | EP | disclosed |
| EP-3604296-A1 | ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT | Heesung Material Ltd. (KR) | 2020-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200123133-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, CYP1A1 | MEN1 351/4885KMT2A 592/4885MAPT 1487/4885 |
| US-11527723-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | MEN1 351/4885KMT2A 592/4885MAPT 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.